Pharmacovigilance Regulations and Application: Safeguarding Drug Safety in a Complex Global Environment
In a pharmaceutical world characterized by rapid innovation and international marketplaces, safeguarding medication safety beyond commercialization has never been more important.
May 6, 2025
by David Orchard-Webb
AI in Pharmacovigilance: Predicting & Preventing Drug Risks
Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.
November 19, 2024
by Nurah Ekhlaque
What is MAH policy in China?
In China, the Marketing Authorization Holder (MAH) system refers to a policy shift in the regulation of pharmaceutical products.
November 9, 2023
by ChatGPT/PharmaSources
Suggesting on the best practice of becoming MAH of a drug in China
Becoming a Marketing Authorization Holder (MAH) for a drug in China involves navigating a complex regulatory landscape.
November 9, 2023
by ChatGTP/PharmaSources
Role of pharmacovigilance in innovating and revolutionising healthcare accessibility in India
Dr Pramod Dhembare, Founder and Managing Partner, Fidelity Health Service, traces the role of pharmacovigilance in public healthcare.
July 29, 2021
by expresspharma
Global pharmacovigilance market to value almost $15bn by 2028
Research suggests outsourcing and the increasing incidence of adverse drug reactions (ADR) will be primary drivers of growth in the global pharmacovigilance market.
April 29, 2021
by europeanpharmaceuticalreview
Pharmacovigilance during a pandemic
As coronavirus has become the new reality for every health worker and life science company to fight in the front, it is time to relook the approach being taken by the industry towards pharmacovigilance.
December 10, 2020
by expresspharma